A phase 3, randomized, double-blind, active-controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.
Overview
publication date
- June 20, 2023
published in
- British journal of haematology Journal
Identity
Digital Object Identifier (DOI)
- 10.1111/bjh.18908
PubMed ID
- 37339869